An Oral Contraceptive Containing Estetrol 15 MG and Drospirenone 3 MG Has Limited Effects on Endocrine and Metabolic Parameters

Background: Most combined oral contraceptives (COCs) contain ethinylestradiol (EE), an estrogen component known to increase the risk of venous thromboembolic events. Previous phase 2 trials have shown that Estetrol (E4), a naturally-occurring estrogen produced by the human fetal liver, in combinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Klipping, Christine, Duijkers, Ingrid J M, Jost, Maud, Bastidas, Adriana, Foidart, Jean Michel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090764/
http://dx.doi.org/10.1210/jendso/bvab048.1482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090764/
http://dx.doi.org/10.1210/jendso/bvab048.1482

Ejemplares similares